Related Experiment Videos
Summary
Intermittent topical clobetasol propionate effectively treated vitiligo, especially on the face in Black and Asian patients. This potent steroid therapy led to significant repigmentation, even after treatment cessation, while minimizing side effects.
Area of Science:
- Dermatology
- Clinical Research
Background:
- Vitiligo is a chronic skin condition causing depigmentation.
- Potent topical steroids are effective but carry risks of adverse effects.
Purpose of the Study:
- To evaluate the efficacy and safety of intermittent topical clobetasol propionate for vitiligo treatment.
- To assess repigmentation rates and identify patient factors influencing outcomes.
Main Methods:
- Seventy-five vitiligo patients received intermittent topical clobetasol propionate over three years.
- Treatment duration and application sites varied among participants.
Main Results:
- Excellent facial repigmentation (90-100%) was observed in over 80% of patients, particularly in Asian or Black individuals.
- Over 40% of patients with vitiligo on other body areas achieved significant repigmentation.
- Continued repigmentation was noted post-treatment, and intermittent therapy reduced local adverse effects.
Conclusions:
- Intermittent topical clobetasol propionate is an effective treatment for vitiligo, yielding high repigmentation rates.
- Facial lesions in darker-skinned patients responded best.
- The intermittent regimen mitigates risks associated with potent steroid use.